FindTrial
Sign In

Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer

Status
Suspended
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00540280
Enrollment
10
Registered
2007-10-05
Start date
2003-10-31
Completion date
2013-10-31
Last updated
2011-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma, Non-Small-Cell Lung

Keywords

NSCLC

Brief summary

Randomized Phase III trial of surgery alone or surgery plus preoperative Gemcitabine-Cisplatin in clinical early stages of non-small cell lung cancer

Interventions

RADIATIONSurgery alone or surgery plus preoperative Gemcitabine-Cisplatin

Surgery + Chemo + RT

Sponsors

King Faisal Specialist Hospital & Research Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients with early stage NSCLC

Design outcomes

Primary

MeasureTime frame
OS, MS, DFSoverall

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026